Cerity Partners LLC Grows Position in Addus HomeCare Co. (NASDAQ:ADUS)

Cerity Partners LLC boosted its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 15.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 71,129 shares of the company's stock after buying an additional 9,578 shares during the period. Cerity Partners LLC owned approximately 0.44% of Addus HomeCare worth $6,604,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Macquarie Group Ltd. boosted its position in Addus HomeCare by 84.0% in the fourth quarter. Macquarie Group Ltd. now owns 287 shares of the company's stock valued at $29,000 after buying an additional 131 shares during the last quarter. Lazard Asset Management LLC acquired a new position in Addus HomeCare in the fourth quarter valued at approximately $30,000. BluePath Capital Management LLC acquired a new position in Addus HomeCare in the third quarter valued at approximately $31,000. Tower Research Capital LLC TRC lifted its holdings in Addus HomeCare by 62.1% in the first quarter. Tower Research Capital LLC TRC now owns 457 shares of the company's stock valued at $49,000 after acquiring an additional 175 shares during the period. Finally, Point72 Hong Kong Ltd acquired a new position in Addus HomeCare in the second quarter valued at approximately $41,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

NASDAQ ADUS traded up $0.26 during mid-day trading on Tuesday, hitting $96.99. The stock had a trading volume of 148,968 shares, compared to its average volume of 113,406. The firm's 50 day moving average is $97.24 and its 200 day moving average is $91.13. Addus HomeCare Co. has a twelve month low of $77.30 and a twelve month high of $114.97. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of 25.26, a PEG ratio of 1.93 and a beta of 0.95.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, February 26th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.04 by $0.17. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The firm had revenue of $276.35 million during the quarter, compared to the consensus estimate of $274.02 million. Equities research analysts forecast that Addus HomeCare Co. will post 4.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ADUS. Royal Bank of Canada reissued an "outperform" rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. Oppenheimer reissued an "outperform" rating and issued a $118.00 price target on shares of Addus HomeCare in a report on Tuesday, March 26th. TheStreet raised Addus HomeCare from a "c+" rating to a "b-" rating in a research note on Friday, December 22nd. Barclays assumed coverage on Addus HomeCare in a research note on Wednesday, March 6th. They set an "equal weight" rating and a $88.00 target price for the company. Finally, William Blair reaffirmed an "outperform" rating on shares of Addus HomeCare in a research note on Monday, February 5th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $103.83.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.